Literature DB >> 15008689

Twelve-week outcomes from an investigation of high-dose nicotine patch therapy for heavy smokers with a past history of alcohol dependence.

David Kalman1, Christopher W Kahler, Dennis Tirch, Cynthia Kaschub, Walter Penk, Peter M Monti.   

Abstract

This study reports findings from an investigation of the efficacy of high-dose nicotine patch (NP) therapy for heavy smokers with a past history of alcohol dependence. One hundred thirty participants were randomly assigned to 42 mg or 21 mg of transdermal nicotine for 4 weeks, followed by an 8-week dose titration. Follow-up assessments were conducted at 4 and 12 weeks. Differences between dose conditions were nonsignificant, although unexpectedly, outcomes favored participants in the 21-mg NP condition. Nicotine abstinence at follow-up was related to longer length of alcohol abstinence at time of enrollment. Future research should investigate ways to improve smoking quit rates in this population, including more frequent counseling sessions and/or other pharmacotherapies. These investigations should focus primarily on smokers in early alcohol recovery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15008689     DOI: 10.1037/0893-164X.18.1.78

Source DB:  PubMed          Journal:  Psychol Addict Behav        ISSN: 0893-164X


  13 in total

1.  Smoking frequency among current college student smokers: distinguishing characteristics and factors related to readiness to quit smoking.

Authors:  Carla J Berg; Pamela M Ling; Rashelle B Hayes; Erin Berg; Nikki Nollen; Eric Nehl; Won S Choi; Jasjit S Ahluwalia
Journal:  Health Educ Res       Date:  2011-12-07

Review 2.  Co-morbidity of smoking in patients with psychiatric and substance use disorders.

Authors:  David Kalman; Sandra Baker Morissette; Tony P George
Journal:  Am J Addict       Date:  2005 Mar-Apr

Review 3.  A tobacco reconceptualization in psychiatry: toward the development of tobacco-free psychiatric facilities.

Authors:  Taryn G Moss; Andrea H Weinberger; Jennifer C Vessicchio; Vincenza Mancuso; Sandra J Cushing; Michael Pett; Kate Kitchen; Peter Selby; Tony P George
Journal:  Am J Addict       Date:  2010 Jul-Aug

4.  Smoking history, nicotine dependence, and changes in craving and mood during short-term smoking abstinence in alcohol dependent vs. control smokers.

Authors:  Jaimee L Heffner; Carolyn Mingione; Thomas J Blom; Robert M Anthenelli
Journal:  Addict Behav       Date:  2010-10-28       Impact factor: 3.913

5.  Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.

Authors:  Nicola Lindson; Samantha C Chepkin; Weiyu Ye; Thomas R Fanshawe; Chris Bullen; Jamie Hartmann-Boyce
Journal:  Cochrane Database Syst Rev       Date:  2019-04-18

6.  A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies.

Authors:  Megan E Piper; Stevens S Smith; Tanya R Schlam; Michael C Fiore; Douglas E Jorenby; David Fraser; Timothy B Baker
Journal:  Arch Gen Psychiatry       Date:  2009-11

Review 7.  Alcohol history and smoking cessation in nicotine replacement therapy, bupropion sustained release and varenicline trials: a review.

Authors:  Robert F Leeman; Christopher J Huffman; Stephanie S O'Malley
Journal:  Alcohol Alcohol       Date:  2007 May-Jun       Impact factor: 2.826

Review 8.  The impact of cigarette smoking on stimulant addiction.

Authors:  Andrea H Weinberger; Mehmet Sofuoglu
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

9.  High dose transdermal nicotine for fast metabolizers of nicotine: a proof of concept placebo-controlled trial.

Authors:  Robert A Schnoll; E Paul Wileyto; Frank T Leone; Rachel F Tyndale; Neal L Benowitz
Journal:  Nicotine Tob Res       Date:  2012-05-15       Impact factor: 4.244

Review 10.  Clinical strategies to enhance the efficacy of nicotine replacement therapy for smoking cessation: a review of the literature.

Authors:  Matthew J Carpenter; Bianca F Jardin; Jessica L Burris; Amanda R Mathew; Robert A Schnoll; Nancy A Rigotti; K Michael Cummings
Journal:  Drugs       Date:  2013-04       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.